HeyJaredBioTalk with Rich Bendis
BioHealth Innovation, Inc. (BHI) Founder, President & CEO, Rich Bendis, hosts BioTalk — conversations with some of the most accomplished and exciting business, academic, and government leaders in the biohealth industry.
- Indexed episodes, last 90 days
- 5
- Latest publication
- Sep 8, 2026
- Audience
- Checking…
- Earliest in this view
- Aug 10, 2026
Latest episodes
Life Sciences Deals, Growth, and the New M&A Market: EY's Subin Baral on What Comes Next (opens the original)
Read excerpt
In this episode of BioTalk with Rich Bendis, Subin Baral, Partner at Ernst & Young LLP and EY-Parthenon Global Life Sciences Deals Leader, joins the conversation to discuss the changing life sciences dealmaking environment and what it means for companies, investors, and regional innovation ecosystems. Subin shares how life sciences companies are shifting from defensive portfolio management toward acquiring earlier-stage assets, technologies, and capabilities that can support long-term growth. He
Maryland Has Grit: Tammi Thomas on TEDCO's Role in Moving Innovation to Market (opens the original)
Read excerpt
In this episode of BioTalk with Rich Bendis, Tammi Thomas, President of TEDCO, joins the conversation to discuss how Maryland is helping entrepreneurs move ideas from research and concept to market. Tammi shares how TEDCO has evolved from an early-stage funding organization into a broader partner for Maryland startups, supporting companies through capital, federal funding navigation, technical assistance, ecosystem connections, and venture development. The conversation touches on what makes Mary
Measuring Brain Health in Real Time: Matt Adams on BrainScope's AI-Enabled Platform (opens the original)
Read excerpt
In this episode of BioTalk with Rich Bendis, Matt Adams, Chief Executive Officer of BrainScope, joins the conversation to discuss how the Rockville-based company is working to bring objective brain function measurement into real-world clinical care. Matt shares how BrainScope is using EEG-based technology and artificial intelligence to help decode brain electrical activity and provide clinicians, patients, and care teams with simple, actionable information. He explains why objective data is espe
Quantum, Real Estate, and Maryland's Opportunity: Travis McCready on What Comes Next (opens the original)
Read excerpt
In this episode of BioTalk with Rich Bendis, Travis McCready, Head of Industries, Leasing Advisory at JLL, joins the conversation to discuss quantum computing, why real estate professionals are paying attention, and what this emerging technology could mean for regions like the BioHealth Capital Region. Travis explains that quantum computing should be understood as an enabling technology, much like earlier waves of innovation that helped shape new industries, companies, and regional economies. Wh
Opening the Door to CDMRP: Dr. Rebecca Fisher on Mission-Driven Medical Research Funding (opens the original)
Read excerpt
In this episode of BioTalk with Rich Bendis, Rebecca "Becky" Fisher, PhD, Deputy Director for Program Management at the Congressionally Directed Medical Research Programs, joins the conversation to help listeners better understand one of the federal biomedical research funding pathways that may be less familiar to many entrepreneurs, researchers, and life science companies. Dr. Fisher explains how CDMRP works, how it differs from and complements other federal funders such as NIH and ARPA-H, and
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.